Stamos Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$17M |
| 2 |
ExxonMobil
XOM
|
+$10.1M |
| 3 |
Merck
MRK
|
+$8.96M |
| 4 |
Chevron
CVX
|
+$8.38M |
| 5 |
BP
BP
|
+$6.84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$17M |
| 2 |
Alibaba
BABA
|
+$2.79M |
| 3 |
Tesla
TSLA
|
+$800K |
| 4 |
Cameco
CCJ
|
+$519K |
| 5 |
Broadcom
AVGO
|
+$434K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.52% |
| 2 | Energy | 15.17% |
| 3 | Technology | 14.1% |
| 4 | Financials | 12.02% |
| 5 | Consumer Discretionary | 7.44% |
Similar funds
Stamos Capital Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Stamos Capital Partners held 142 positions worth $557M, up 46% from $382M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Stamos Capital Partners deployed $153M of net new capital in Q2 2025, opening 2 new positions and adding to 124 existing holdings. Its largest new stake was iShares MSCI South Korea ETF: 25,182 shares worth $1.81M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $17M trimmed.
- Stamos Capital Partners's largest Q2 2025 buy was iShares MSCI South Korea ETF: 25,182 shares worth $1.81M.
- Stamos Capital Partners added most to UnitedHealth in Q2 2025, an estimated $17M increase.
- Stamos Capital Partners's biggest Q2 2025 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $17M.
- Stamos Capital Partners fully exited Alibaba in Q2 2025, selling an estimated $2.79M.
- Stamos Capital Partners's ten largest holdings make up 32% of its $557M portfolio in Q2 2025.
- Stamos Capital Partners opened 2 new positions and closed 4 in Q2 2025.
- Stamos Capital Partners's portfolio value rose 46% quarter-over-quarter to $557M.
Based on Stamos Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.